Literature DB >> 6563062

The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma.

A Unterberg, A J Baethmann.   

Abstract

Plasma and bradykinin were perfused into the ventricular system of mongrel dogs to investigate whether either or both induce brain edema. Formation of cerebral edema was determined by measurement of cerebral water and electrolytes in periventricular white matter, cerebral cortex, and caudate nucleus. The response of cerebral tissue to exposure to bradykinin or to plasma, as a carrier of kininogens, was analyzed by assessment of the perfusate composition after ventricle passage. The authors report that cerebral administration of bradykinin induces cerebral edema. Ventricular perfusion with plasma also led to an increase of cerebral water content which was restricted to the white matter, but involved all brain tissue areas, if bradykinin was used. Ventricular perfusion with plasma was associated with consumption of the kinin precursor (kininogens) indicative of formation of kinins. Significant consumption of the precursor was found in five out of nine animals subjected to plasma perfusion of the ventricular system. In these animals a close correlation between the increase of white matter water content and kininogen-consumption as a measure of kinin-formation was obtained. Marked kinin-degrading activity was observed during ventricular perfusion with bradykinin as concluded from a considerable decrease of bradykinin concentration in the cisternal effluent compared to the inflowing perfusate concentration. Ventricular perfusion with plasma was associated with a decrease of K+ clearance capacity with continued duration, and in two animals with a release of glutamate into the plasma perfusate, suggesting an involvement of cytotoxic mechanisms. These findings provide support for the hypothesis of a mediator function of the kallikrein-kinin (KK) system in vasogenic brain edema. The next question that needs to be answered to complete the picture--does spontaneous activation of the KK system occur in conditions leading to vasogenic edema?--is studied in a subsequent report.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6563062     DOI: 10.3171/jns.1984.61.1.0087

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  Critical appraisal of neuroprotection trials in head injury: what have we learned?

Authors:  Christos M Tolias; M Ross Bullock
Journal:  NeuroRx       Date:  2004-01

2.  The role of bradykinin in the etiology of vasogenic brain edema and perilesional brain dysfunction.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone.

Authors:  L Schürer; P Temesvari; M Wahl; A Unterberg; A Baethmann
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 4.  Pharmacological blood-brain barrier modification for selective drug delivery.

Authors:  T F Cloughesy; K L Black
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

5.  The importance of protein content in the oedema fluid for the resolution of brain oedema.

Authors:  U Groeger; A Marmarou
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

6.  The effects of endothelium-dependent vasodilators on cardiac output and their distribution in the anaesthetized rat: a comparison with sodium nitroprusside.

Authors:  G R Thomas; C Thiemermann; C Walder; J R Vane
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

7.  The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice.

Authors:  Raimund Trabold; Christian Erös; Klaus Zweckberger; Jane Relton; Heike Beck; Juerg Nussberger; Werner Müller-Esterl; Michael Bader; Eric Whalley; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

8.  Neuropathological and neurophysiological effects of interstitial white matter autologous and non-autologous protein containing solutions: further evidence for a glioma derived permeability factor.

Authors:  I R Whittle; J W Ironside; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.

Authors:  Li Ding-Zhou; Isabelle Margaill; Bruno Palmier; Didier Pruneau; Michel Plotkine; Catherine Marchand-Verrecchia
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 10.  Prognostic significance of proteolytic enzymes in human brain tumors.

Authors:  A K Bindal; M Hammoud; W M Shi; S Z Wu; R Sawaya; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.